FDA Microbiology Devices Panel Votes Down Sepsis' Endotoxin Activity Assay
This article was originally published in The Gray Sheet
Executive Summary
Sepsis, Inc.' s endotoxin activity assay (EAA) suffered in FDA panel review partly because of the changing nature of bacterial infection in intensive care units.